Colin Farrell has typically been very private about his home life, but now he’s opening up about his experience having a child with Angelman syndrome. Despite being relatively common, affecting 1 in ...

Actor Colin Farrell recently disclosed that his son, James, has Angelman syndrome, one of the driving factors behind Farrell's support for finding a cure for Angelman syndrome and for launching the ...

Mothers are often encouraged to trust their instincts, especially regarding their children's health. But for Tiffany Young, getting others to take her concerns seriously proved challenging when her ...

Actor Colin Farrell, long an advocate for people with intellectual disabilities, has started a foundation in honor of his son, James, who suffers from Angelman syndrome, a rare neurogenetic disorder.

Colin Farrell is opening up about life with his 20-year-old son who has Angelman syndrome. The Irish actor is sharing details of James’ life as they prepare for his 21st birthday, a milestone when ...

A new review sheds light on the complex molecular mechanisms behind Angelman syndrome (AS), a rare neurogenetic disorder, and explores how cutting-edge gene-targeting therapies may offer more ...

Massachusetts General Hospital in Boston announced the opening of its new Angelman Syndrome Clinic — one of only two in the country, according to the release. The clinic was established through a ...

The Pinball Lounge at 78th Street Sudios offers an ideal setting for this unique fundraiser. The event runs from 4-6 pm, providing families with an accessible Sunday afternoon activity. True to its ...

ORLANDO, Fla.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, announced today that ...

ION582 showed robust and consistent benefit in communication, cognition and motor function in a broad patient population evaluated with a comprehensive set of assessment tools that collect input from ...

MIDDLETON, Mass., Sept. 22, 2025 /PRNewswire/ -- MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today ...